Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond.

Pasquini MC, Srivastava A, Ahmed SO, Aljurf M, Atsuta Y, Doleysh C, Galeano S, Gluckman E, Greinix H, Hale G, Hari P, Hashmi SK, Kamani N, Laughlin MJ, Niederwieser D, Seber A, Szer J, Snowden JA, Van Biesen K, Watry P, Weisdorf DJ, Apperley J.

Hematol Oncol Stem Cell Ther. 2019 Aug 20. pii: S1658-3876(19)30054-8. doi: 10.1016/j.hemonc.2019.08.001. [Epub ahead of print]

2.

Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond.

Pasquini MC, Srivastava A, Ahmed SO, Aljurf M, Atsuta Y, Doleysh C, Galeano S, Gluckman E, Greinix H, Hale GA, Hari P, Hashmi SK, Kamani N, Laughlin MJ, Niederwieser D, Seber A, Szer J, Snowden JA, Van Biesen K, Watry P, Weisdorf DJ, Apperley J.

Biol Blood Marrow Transplant. 2019 Dec;25(12):2322-2329. doi: 10.1016/j.bbmt.2019.05.002. Epub 2019 May 6.

3.

Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601.

King AA, McKinstry RC, Wu J, Eapen M, Abel R, Varughese T, Kamani N, Shenoy S.

Biol Blood Marrow Transplant. 2019 May;25(5):e174-e178. doi: 10.1016/j.bbmt.2019.01.008. Epub 2019 Jan 11.

PMID:
30639825
4.

Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.

Krishnamurti L, Neuberg DS, Sullivan KM, Kamani NR, Abraham A, Campigotto F, Zhang W, Dahdoul T, De Castro L, Parikh S, Bakshi N, Haight A, Hassell KL, Loving R, Rosenthal J, Smith SL, Smith W, Spearman M, Stevenson K, Wu CJ, Wiedl C, Waller EK, Walters MC.

Am J Hematol. 2019 Apr;94(4):446-454. doi: 10.1002/ajh.25401. Epub 2019 Feb 11.

5.

Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors.

Majhail NS, Murphy E, Laud P, Preussler JM, Denzen EM, Abetti B, Adams A, Besser R, Burns LJ, Cerny J, Drexler R, Hahn T, Idossa L, Jahagirdar B, Kamani N, Loren A, Mattila D, McGuirk J, Moore H, Reynolds J, Saber W, Salazar L, Schatz B, Stiff P, Wingard JR, Syrjala KL, Baker KS.

Haematologica. 2019 May;104(5):1084-1092. doi: 10.3324/haematol.2018.203919. Epub 2018 Dec 4.

6.

Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients.

Bhatt ST, Bednarski JJ, Berg J, Trinkaus K, Murray L, Hayashi R, Schulz G, Hente M, Grimley M, Chan KW, Kamani N, Jacobsohn D, Nieder M, Hale G, Yu L, Adams R, Dalal J, Pulsipher MA, Haut P, Chaudhury S, Davis J, Jaroscak J, Andreansky M, Willert J, Shenoy S.

Biol Blood Marrow Transplant. 2019 Mar;25(3):556-561. doi: 10.1016/j.bbmt.2018.10.008. Epub 2018 Oct 12.

PMID:
30321596
7.

Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation.

Denzen EM, Preussler JM, Murphy EA, Baker KS, Burns LJ, Foster J, Idossa L, Moore HK, Payton TJ, Haven D, Jahagirdar B, Kamani N, Rizzo JD, Salazar L, Schatz BA, Syrjala KL, Wingard JR, Majhail NS.

Biol Blood Marrow Transplant. 2019 Mar;25(3):562-569. doi: 10.1016/j.bbmt.2018.10.005. Epub 2018 Oct 10.

PMID:
30315940
8.

Access to hematopoietic stem cell transplant for patients with sickle cell anemia.

Meier ER, Johnson T, Pinkney K, Velez MC, Kamani N, Odame I.

Pediatr Blood Cancer. 2018 Sep;65(9):e27105. doi: 10.1002/pbc.27105. Epub 2018 Apr 25. Review.

PMID:
29693782
9.

Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study.

Spellecy R, Tarima S, Denzen E, Moore H, Abhyankar S, Dawson P, Foley A, Gersten I, Horwitz M, Idossa L, Joffe S, Kamani N, King R, Lazaryan A, Morris L, Horowitz MM, Majhail NS.

Biol Blood Marrow Transplant. 2018 Oct;24(10):2145-2151. doi: 10.1016/j.bbmt.2018.04.014. Epub 2018 Apr 18.

10.

Surveys of blood collection and utilization.

Whitaker BI, Kamani N.

Transfusion. 2018 Feb;58(2):541-542. doi: 10.1111/trf.14436. No abstract available.

PMID:
29411395
11.

Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell Disease.

Abraham A, Hsieh M, Eapen M, Fitzhugh C, Carreras J, Keesler D, Guilcher G, Kamani N, Walters MC, Boelens JJ, Tisdale J, Shenoy S; National Institutes of Health; Center for International Blood and Marrow Transplant Research.

Biol Blood Marrow Transplant. 2017 Dec;23(12):2178-2183. doi: 10.1016/j.bbmt.2017.08.038. Epub 2017 Sep 4.

12.

Ethical Challenges in Hematopoietic Cell Transplantation for Sickle Cell Disease.

Nickel RS, Kamani NR.

Biol Blood Marrow Transplant. 2018 Feb;24(2):219-227. doi: 10.1016/j.bbmt.2017.08.034. Epub 2017 Sep 1. Review.

13.

Obstetric hemorrhage and safe blood for transfusion in Ethiopia: the challenges of bridging the gap.

Taye Makuria A, Gebremichael D, Demoz H, Hadush A, Abdella Y, Berhane Y, Kamani N.

Transfusion. 2017 Oct;57(10):2526-2531. doi: 10.1111/trf.14219. Epub 2017 Jul 13. Review.

PMID:
28703878
14.

A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.

Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, Haines H, Jaroscak J, Lazarus HM, Levine JE, Krishnamurti L, Margolis D, Megason GC, Yu LC, Pulsipher MA, Gersten I, DiFronzo N, Horowitz MM, Walters MC, Kamani N.

Blood. 2016 Nov 24;128(21):2561-2567. Epub 2016 Sep 13.

15.

Trends in United States blood collection and transfusion: results from the 2013 AABB Blood Collection, Utilization, and Patient Blood Management Survey.

Whitaker B, Rajbhandary S, Kleinman S, Harris A, Kamani N.

Transfusion. 2016 Sep;56(9):2173-83. doi: 10.1111/trf.13676. Epub 2016 Jun 15. Erratum in: Transfusion. 2016 Dec;56(12 ):3149.

PMID:
27301995
16.

Mesenchymal stromal cells: are they ready for prime time?

Kamani NR.

Transfusion. 2016 Apr;56(4):1S. doi: 10.1111/trf.13560. No abstract available.

PMID:
27079317
17.

Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.

Walters MC, De Castro LM, Sullivan KM, Krishnamurti L, Kamani N, Bredeson C, Neuberg D, Hassell KL, Farnia S, Campbell A, Petersdorf E.

Biol Blood Marrow Transplant. 2016 Feb;22(2):207-211. doi: 10.1016/j.bbmt.2015.10.017. Epub 2015 Oct 21. Review.

18.

Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies.

King AA, Kamani N, Bunin N, Sahdev I, Brochstein J, Hayashi RJ, Grimley M, Abraham A, Dioguardi J, Chan KW, Douglas D, Adams R, Andreansky M, Anderson E, Gilman A, Chaudhury S, Yu L, Dalal J, Hale G, Cuvelier G, Jain A, Krajewski J, Gillio A, Kasow KA, Delgado D, Hanson E, Murray L, Shenoy S.

Am J Hematol. 2015 Dec;90(12):1093-8. doi: 10.1002/ajh.24183. Epub 2015 Oct 6.

19.

Current attitudes of parents and patients toward hematopoietic stem cell transplantation for sickle cell anemia.

Meier ER, Dioguardi JV, Kamani N.

Pediatr Blood Cancer. 2015 Jul;62(7):1277-84. doi: 10.1002/pbc.25446. Epub 2015 Mar 23.

PMID:
25809231
20.

Systemic injection of CD34(+)-enriched human cord blood cells modulates poststroke neural and glial response in a sex-dependent manner in CD1 mice.

Kadam SD, Chen H, Markowitz GJ, Raja S, George S, Verina T, Shotwell E, Loechelt B, Johnston MV, Kamani N, Fatemi A, Comi AM.

Stem Cells Dev. 2015 Jan 1;24(1):51-66. doi: 10.1089/scd.2014.0135. Erratum in: Stem Cells Dev. 2015 Apr 1;24(7):916.

21.

Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.

Ringdén O, Brazauskas R, Wang Z, Ahmed I, Atsuta Y, Buchbinder D, Burns LJ, Cahn JY, Duncan C, Hale GA, Halter J, Hayashi RJ, Hsu JW, Jacobsohn DA, Kamble RT, Kamani NR, Kasow KA, Khera N, Lazarus HM, Loren AW, Marks DI, Myers KC, Ramanathan M, Saber W, Savani BN, Schouten HC, Socie G, Sorror ML, Steinberg A, Popat U, Wingard JR, Mattsson J, Majhail NS.

Biol Blood Marrow Transplant. 2014 Nov;20(11):1777-84. doi: 10.1016/j.bbmt.2014.07.009. Epub 2014 Jul 17.

22.

Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.

Angelucci E, Matthes-Martin S, Baronciani D, Bernaudin F, Bonanomi S, Cappellini MD, Dalle JH, Di Bartolomeo P, de Heredia CD, Dickerhoff R, Giardini C, Gluckman E, Hussein AA, Kamani N, Minkov M, Locatelli F, Rocha V, Sedlacek P, Smiers F, Thuret I, Yaniv I, Cavazzana M, Peters C; EBMT Inborn Error and EBMT Paediatric Working Parties.

Haematologica. 2014 May;99(5):811-20. doi: 10.3324/haematol.2013.099747.

23.

Clinical guide to fertility preservation in hematopoietic cell transplant recipients.

Joshi S, Savani BN, Chow EJ, Gilleece MH, Halter J, Jacobsohn DA, Pidala J, Quinn GP, Cahn JY, Jakubowski AA, Kamani NR, Lazarus HM, Rizzo JD, Schouten HC, Socie G, Stratton P, Sorror ML, Warwick AB, Wingard JR, Loren AW, Majhail NS.

Bone Marrow Transplant. 2014 Apr;49(4):477-84. doi: 10.1038/bmt.2013.211. Epub 2014 Jan 13. Review.

24.

An educational symposium for patients with sickle cell disease and their families: results from surveys of knowledge and factors influencing decisions about hematopoietic stem cell transplant.

Thompson AL, Bridley A, Twohy E, Dioguardi J, Sande J, Hsu LL, Kamani N, Meier ER.

Pediatr Blood Cancer. 2013 Dec;60(12):1946-51. doi: 10.1002/pbc.24704. Epub 2013 Jul 30.

PMID:
23900784
25.

Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience.

Hale GA, Arora M, Ahn KW, He W, Camitta B, Bishop MR, Bitan M, Cairo MS, Chan K, Childs RW, Copelan E, Davies SM, Perez MA, Doyle JJ, Gale RP, Vicent MG, Horn BN, Hussein AA, Jodele S, Kamani NR, Kasow KA, Kletzel M, Lazarus HM, Lewis VA, Myers KC, Olsson R, Pulsipher M, Qayed M, Sanders JE, Shaw PJ, Soni S, Stiff PJ, Stadtmauer EA, Ueno NT, Wall DA, Grupp SA.

Bone Marrow Transplant. 2013 Aug;48(8):1056-64. doi: 10.1038/bmt.2012.284. Epub 2013 Feb 18.

26.

Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).

Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, Eapen M, Freed BM, Grimley M, Levine JE, Logan B, Moore T, Panepinto J, Parikh S, Pulsipher MA, Sande J, Schultz KR, Spellman S, Shenoy S.

Biol Blood Marrow Transplant. 2012 Aug;18(8):1265-72. doi: 10.1016/j.bbmt.2012.01.019. Epub 2012 Feb 16.

27.

Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.

Sokolic R, Maric I, Kesserwan C, Garabedian E, Hanson IC, Dodds M, Buckley R, Issekutz AC, Kamani N, Shaw K, Tan B, Bali P, Hershfield MS, Kohn DB, Wayne AS, Candotti F.

Blood. 2011 Sep 8;118(10):2688-94. doi: 10.1182/blood-2011-01-329359. Epub 2011 Jul 1. Erratum in: Blood. 2014 Mar 13;123(11):1767.

28.

Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research.

Kamani NR, Kumar S, Hassebroek A, Eapen M, LeRademacher J, Casper J, Cowan M, Sánchez de Toledo J, Ferster A, Szabolcs P, Wingard JR, Horwitz E, Filipovich AH.

Biol Blood Marrow Transplant. 2011 Dec;17(12):1783-9. doi: 10.1016/j.bbmt.2011.05.008. Epub 2011 May 20.

29.

CD34⁺ collection efficiency as a function of blood volumes processed in pediatric autologous peripheral blood stem cell collection.

Dubrovsky L, Wong EC, Perez-Albuerne E, Loechelt B, Kamani N, Sande J, Mintz K, Paul W, Luban NL, Rood BR, Fry T.

J Clin Apher. 2011;26(3):131-7. doi: 10.1002/jca.20281. Epub 2011 Feb 3.

PMID:
21294153
30.

Ethical considerations in pediatric BMT donors and recipients.

Kamani N, Lantos JD, Myers D, Kahn JP.

Biol Blood Marrow Transplant. 2011 Jan;17(1 Suppl):S132-6. doi: 10.1016/j.bbmt.2010.11.007. Review. No abstract available.

31.

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.

Shaw PJ, Kan F, Woo Ahn K, Spellman SR, Aljurf M, Ayas M, Burke M, Cairo MS, Chen AR, Davies SM, Frangoul H, Gajewski J, Gale RP, Godder K, Hale GA, Heemskerk MB, Horan J, Kamani N, Kasow KA, Chan KW, Lee SJ, Leung WH, Lewis VA, Miklos D, Oudshoorn M, Petersdorf EW, Ringdén O, Sanders J, Schultz KR, Seber A, Setterholm M, Wall DA, Yu L, Pulsipher MA.

Blood. 2010 Nov 11;116(19):4007-15. doi: 10.1182/blood-2010-01-261958. Epub 2010 Jul 29.

32.

Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).

Loren AW, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S, Wang Z, Sobocinski KA, Gupta V, Hale GA, Marks DI, Stadtmauer EA, Apperley J, Cahn JY, Schouten HC, Lazarus HM, Savani BN, McCarthy PL, Jakubowski AA, Kamani NR, Hayes-Lattin B, Maziarz RT, Warwick AB, Sorror ML, Bolwell BJ, Socié G, Wingard JR, Rizzo JD, Majhail NS.

Biol Blood Marrow Transplant. 2011 Feb;17(2):157-66. doi: 10.1016/j.bbmt.2010.07.009. Epub 2010 Jul 24. Review.

33.

RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management.

Fasano RM, Monaco A, Meier ER, Pary P, Lee-Stroka AH, Otridge J, Klein HG, Marincola FM, Kamani NR, Luban NL, Stroncek D, Flegel WA.

Blood. 2010 Oct 14;116(15):2836-8. doi: 10.1182/blood-2010-04-279372. Epub 2010 Jul 19.

34.

Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency.

Walter JE, Rucci F, Patrizi L, Recher M, Regenass S, Paganini T, Keszei M, Pessach I, Lang PA, Poliani PL, Giliani S, Al-Herz W, Cowan MJ, Puck JM, Bleesing J, Niehues T, Schuetz C, Malech H, DeRavin SS, Facchetti F, Gennery AR, Andersson E, Kamani NR, Sekiguchi J, Alenezi HM, Chinen J, Dbaibo G, ElGhazali G, Fontana A, Pasic S, Detre C, Terhorst C, Alt FW, Notarangelo LD.

J Exp Med. 2010 Jul 5;207(7):1541-54. doi: 10.1084/jem.20091927. Epub 2010 Jun 14.

35.

The experiences of children enrolled in pediatric oncology research: implications for assent.

Unguru Y, Sill AM, Kamani N.

Pediatrics. 2010 Apr;125(4):e876-83. doi: 10.1542/peds.2008-3429. Epub 2010 Mar 29.

PMID:
20351001
36.

Altered functional balance of Gfi-1 and Gfi-1b as an alternative cause of reticular dysgenesis?

Barjaktarevic I, Maletkovic-Barjaktarevic J, Kamani NR, Vukmanovic S.

Med Hypotheses. 2010 Mar;74(3):445-8. doi: 10.1016/j.mehy.2009.09.053. Epub 2009 Nov 6.

PMID:
19896777
37.

Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.

Walters MC, Hardy K, Edwards S, Adamkiewicz T, Barkovich J, Bernaudin F, Buchanan GR, Bunin N, Dickerhoff R, Giller R, Haut PR, Horan J, Hsu LL, Kamani N, Levine JE, Margolis D, Ohene-Frempong K, Patience M, Redding-Lallinger R, Roberts IA, Rogers ZR, Sanders JE, Scott JP, Sullivan KM; Multicenter Study of Bone Marrow Transplantation for Sickle Cell Disease.

Biol Blood Marrow Transplant. 2010 Feb;16(2):263-72. doi: 10.1016/j.bbmt.2009.10.005. Epub 2009 Oct 12.

38.

Hematopoietic stem cell transplantation for pediatric autoimmune disease: where we stand and where we need to go.

Krauss AC, Kamani NR.

Bone Marrow Transplant. 2009 Aug;44(3):137-43. doi: 10.1038/bmt.2009.147. Epub 2009 Jul 13. Review.

PMID:
19597421
39.

Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs.

Griffith LM, Cowan MJ, Kohn DB, Notarangelo LD, Puck JM, Schultz KR, Buckley RH, Eapen M, Kamani NR, O'Reilly RJ, Parkman R, Roifman CM, Sullivan KE, Filipovich AH, Fleisher TA, Shearer WT.

J Allergy Clin Immunol. 2008 Dec;122(6):1087-96. doi: 10.1016/j.jaci.2008.09.045. Epub 2008 Nov 6.

40.

National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants.

Bray RA, Hurley CK, Kamani NR, Woolfrey A, Müller C, Spellman S, Setterholm M, Confer DL.

Biol Blood Marrow Transplant. 2008 Sep;14(9 Suppl):45-53. doi: 10.1016/j.bbmt.2008.06.014. Review. No abstract available.

41.

Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.

Baker KS, Filipovich AH, Gross TG, Grossman WJ, Hale GA, Hayashi RJ, Kamani NR, Kurian S, Kapoor N, Ringdén O, Eapen M.

Bone Marrow Transplant. 2008 Aug;42(3):175-80. doi: 10.1038/bmt.2008.133. Epub 2008 May 5.

PMID:
18454181
42.

Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia.

Perez-Albuerne ED, Eapen M, Klein J, Gross TJ, Lipton JM, Baker KS, Woolfrey A, Kamani N.

Br J Haematol. 2008 Apr;141(2):216-23. doi: 10.1111/j.1365-2141.2008.07030.x. Epub 2008 Feb 26.

43.

Rethinking pediatric assent: from requirement to ideal.

Unguru Y, Coppes MJ, Kamani N.

Pediatr Clin North Am. 2008 Feb;55(1):211-22, xii. doi: 10.1016/j.pcl.2007.10.016. Review.

PMID:
18242322
44.

Principles and tools for selection of umbilical cord blood and unrelated adult donor grafts.

Lee SJ, Kamani N, Confer DL.

Biol Blood Marrow Transplant. 2008 Jan;14(1 Suppl 1):112-9. doi: 10.1016/j.bbmt.2007.11.009. Review. Erratum in: Biol Blood Marrow Transplant. 2008 Nov;14(11):1317-8.

45.

State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants.

Kamani N, Spellman S, Hurley CK, Barker JN, Smith FO, Oudshoorn M, Bray R, Smith A, Williams TM, Logan B, Eapen M, Anasetti C, Setterholm M, Confer DL; National Marrow Donor Program.

Biol Blood Marrow Transplant. 2008 Jan;14(1):1-6. Review. No abstract available.

46.

Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.

Choi LM, Rood B, Kamani N, La Fond D, Packer RJ, Santi MR, Macdonald TJ.

Pediatr Blood Cancer. 2008 May;50(5):970-5.

PMID:
17941070
47.

Immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: an unusual cause of proteinuria in infancy.

Moudgil A, Perriello P, Loechelt B, Przygodzki R, Fitzerald W, Kamani N.

Pediatr Nephrol. 2007 Oct;22(10):1799-802. Epub 2007 Jul 13.

PMID:
17629750
48.

Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia.

Eggleston B, Patience M, Edwards S, Adamkiewicz T, Buchanan GR, Davies SC, Dickerhoff R, Donfield S, Feig SA, Giller RH, Haight A, Horan J, Hsu LL, Kamani N, Lane P, Levine JE, Margolis D, Moore TB, Ohene-Frempong K, Redding-Lallinger R, Roberts IA, Rogers ZR, Sanders JE, Scott JP, Sleight B, Thompson AA, Sullivan KM, Walters MC; Multicenter Study of HCT for SCA.

Br J Haematol. 2007 Feb;136(4):673-6.

PMID:
17223910
49.

Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.

Rao A, Kamani N, Filipovich A, Lee SM, Davies SM, Dalal J, Shenoy S.

Blood. 2007 Jan 1;109(1):383-5. Epub 2006 Sep 21.

PMID:
16990602
50.

The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.

Farag SS, Bacigalupo A, Eapen M, Hurley C, Dupont B, Caligiuri MA, Boudreau C, Nelson G, Oudshoorn M, van Rood J, Velardi A, Maiers M, Setterholm M, Confer D, Posch PE, Anasetti C, Kamani N, Miller JS, Weisdorf D, Davies SM; KIR Study Group, Center for International Blood and Marrow Transplantation Research.

Biol Blood Marrow Transplant. 2006 Aug;12(8):876-84.

Supplemental Content

Loading ...
Support Center